Floatz logo

Vincristine Sulfate

Small Intestine Cancer

Cancer Research UKSmall moleculePhase 2Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
81/ 100

Competitive context

19 Active assets in the Small Intestine Cancer cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
National Cancer Institute (NCI)
Phase 2BB
Etoposide
Cancer Research UK
Phase 2BB
Nivestim
Cancer Research UK
Phase 2BB
Adriamycin
Cancer Research UK
Phase 2B
Carboplatin
National Cancer Institute (NCI)
Phase 2B

View all 49 →

Same molecule, other indications

Vincristine Sulfate is also rated in:

B-cell childhood acute lymphoblastic leukemiaDormant
A
Indicative · Phase 3
81 / 100
View asset →
diffuse large B-cell lymphomaActive
A
Indicative · Phase 2/3
80 / 100
View asset →
childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →